BreEStim in Managing Neuropathic Pain After Spinal Cord Injury (SCI)
Part of paid clinical trials in Houston, Texas.
- Sponsor
- The University of Texas Health Science Center, Houston
- Study ID
- NCT07659743
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Pain Management
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Active BreEStim Treatment — DEVICEDuring the Active BreEStim Treatment session, participants will remain relaxed while breathing is monitored using a nasal cannula. Surface electrodes will be placed over the median nerve at the wrist or another selected peripheral nerve. Electrical stimulation will be synchronized with voluntary breathing and delivered at an individually tolerated intensity for approximately 30 minutes.
- Sham BreEStim Treatment — DEVICEDuring the Sham BreEStim Treatment session, participants will remain relaxed while breathing is monitored using a nasal cannula. Surface electrodes will be placed over the median nerve at the wrist or another selected peripheral nerve. Electrical stimulation will be synchronized with voluntary breathing and delivered at the sensory threshold level for approximately 30 minutes.
- The TENS Treatment — DEVICEDuring the TENS Treatment session, participants will remain relaxed while transcutaneous electrical stimulation is applied through surface electrodes placed over the painful area. Stimulation will be delivered at an individually tolerated intensity for approximately 30 minutes.
Study Details
The purpose of this study is to compare the effectiveness of innovative intervention of breathing controlled electrical stimulation (BreEStim) and sham BreEStim and Transcutaneous Electrical Nerve Stimulation (TENS) in management of neuropathic pain in patients after spinal cord injury (SCI).
Key Dates
- Start date
- Oct 1, 2026
- Status verified
- Jun 2026
- Primary completion
- Jul 31, 2029
- Completion
- Sep 30, 2029
Study Design
- Enrollment
- 66 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Active BreEStim Treatment
- Sham Comparator: Sham BreEStim Treatment
- Active Comparator: The transcutaneous electrical nerve stimulation (TENS) Treatment
Primary Outcome Measure
Change in Pain Level as Measured by the Visual Analog Scale (VAS). [ Time Frame: Baseline, 10-15 minutes after intervention ]
Central Contacts
- Sheng Li, MD, PhD(713) 797-7125
- Shengai Li, MS713-797-7561
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 |
Find similar trials in Houston, TX
Related Studies
- Effectiveness of Bupivacaine, Ketorolac, Ketamine, vs Bupivacaine Alone in Reducing Postoperative Pocket PainPHASE1 · Not Yet Recruiting · Kansas City Heart Rhythm Research Foundation · Loma Linda, California
- Efficacy of Liposomal Bupivacaine Post SeptorhinoplastyPHASE3 · Enrolling By Invitation · Jessyka Lighthall · Hershey, Pennsylvania
- Psilocybin in Cancer Pain StudyPHASE2 · Recruiting · Yvan Beaussant, MD, MSci · Boston, Massachusetts
- Local Anesthesia for Facial FracturesPHASE2 · Recruiting · Washington University School of Medicine · St Louis, Missouri